Nephrotoxic Biomarkers with Specific Indications for Metallic Pollutants: Implications for Environmental Health

by István Pócsi, Mark E Dockrell, Robert G Price
Published 2022-07-01

Urinary Biomarkers of Mycotoxin Induced Nephrotoxicity—Current Status and Expected Future Trends

by Zsolt Ráduly, Robert G. Price, Mark E. C. Dockrell, László Csernoch, István Pócsi
Published 2021-11-01

The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study

by Erika Bíró, István Szegedi, Csongor Kiss, Anna V. Oláh, Mark Dockrell, Robert G. Price, Tamás Szabó
Published 2022-07-01

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis

by Charlene M. Prazma, Elisabeth H. Bel, Robert G. Price, Eric S. Bradford, Frank C. Albers, Steven W. Yancey
Published 2019-05-01

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab

by Ian D. Pavord, Roland Buhl, Monica Kraft, Charlene M. Prazma, Robert G. Price, Peter H. Howarth, Steven W. Yancey
Published 2022-05-01

Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma

by Stephanie Korn, Peter Howarth, Steven G. Smith, Robert G. Price, Steven W. Yancey, Charlene M. Prazma, Elisabeth H. Bel
Published 2022-03-01

Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports

by Laura Pini, Cristiano Caruso, Stefania Colantuono, Diego Bagnasco, Aoife Maxwell, Robert G. Price, Peter Howarth, Giorgio Walter Canonica, Italian investigators of REALITI‐A
Published 2021-10-01

New perspectives in application of kidney biomarkers in mycotoxin induced nephrotoxicity, with a particular focus on domestic pigs

by Zsolt Ráduly, Zsolt Ráduly, Zsolt Ráduly, András Szabó, András Szabó, Miklós Mézes, Miklós Mézes, Ildikó Balatoni, Robert G. Price, Mark E. Dockrell, Mark E. Dockrell, István Pócsi, László Csernoch
Published 2023-04-01

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics

by Mark C. Liu, Bradley Chipps, Xavier Munoz, Gilles Devouassoux, Miguel Bergna, Steven G. Smith, Robert G. Price, Dmitry V. Galkin, Jay Azmi, Dalal Mouneimne, Frank C. Albers, Kenneth R. Chapman
Published 2021-05-01

Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study

by Ian Pavord, Frances Gardiner, Liam G. Heaney, Christian Domingo, Robert G. Price, Alison Pullan, John Oppenheimer, Guy Brusselle, Hiroyuki Nagase, Geoffrey Chupp, Emilio Pizzichini, Emilio Pizzichini, David Bañas-Conejero, Peter Howarth
Published 2023-04-01

The effects of dexamphetamine on the resting-state electroencephalogram and functional connectivity

by Albrecht, Matthew, Roberts, G., Price, G., Lee, J., Iyyalol, R., Martin-Iverson, M.
Published 2015